SCHEMBL17340652

SCHEMBL17340652

CCOC(=O)N1CCN(Cc2ccn(Cc3ccc(Cl)cc3)c(=O)c2N=O)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VEGFA P15692 1/20 0.60
EGLN1 Q9GZT9 1/20 0.60
ALDH1A1 P00352 9/20 0.51
DRD2 P14416 1/20 0.51
DRD4 P21917 1/20 0.51
TSHR P16473 2/20 0.49
KDM4E B2RXH2 2/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2C19 P33261 2/20 0.48
HTT P42858 2/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
MAPT P10636 3/20 0.46
LMNA P02545 3/20 0.46
KMT2A Q03164 2/20 0.46
CYP3A4 P08684 1/20 0.46
HPGD P15428 1/20 0.46
POLB P06746 2/20 0.46
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15314772 0.88 VEGFA (0.77) VEGFAEGLN1ALDH1A1DRD2DRD4
SCHEMBL1770695 0.87 VEGFA (0.78) VEGFAEGLN1ALDH1A1DRD2DRD4
SCHEMBL17005908 0.81 VEGFA (0.66) VEGFAEGLN1ALDH1A1DRD2DRD4
SCHEMBL17005962 0.79 VEGFA (0.67) VEGFAEGLN1ALDH1A1DRD2DRD4
SCHEMBL11093397 0.79 DRD2 (0.70) ALDH1A1DRD2DRD4TSHRKDM4E
SCHEMBL1770457 0.78 EGLN1 (0.63) VEGFAEGLN1ALDH1A1DRD2DRD4
SCHEMBL1770870 0.78 VEGFA (0.71) VEGFAEGLN1ALDH1A1DRD2DRD4
SCHEMBL30963341 0.78 EGLN1 (0.63) VEGFAEGLN1ALDH1A1DRD2DRD4
SCHEMBL17005862 0.78 VEGFA (0.64) VEGFAEGLN1ALDH1A1DRD2DRD4
SCHEMBL1770264 0.78 VEGFA (0.64) VEGFAEGLN1ALDH1A1TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2954899-A1 COMPOSITIONS AND METHODS FOR TREATING COLITIS Aerpio Therapeutics, Inc. (US) 2015-12-16 EP disclosed